Median overall survival and progression-free survival hazard ratios (HRs) and 95% Credible Intervals for cabazitaxel, abiraterone and enzalutamide using Bayesian fixed effects modeling.

Median overall survival and progression-free survival hazard ratios (HRs) and 95% Credible Intervals for cabazitaxel, abiraterone and enzalutamide using Bayesian fixed effects modeling.

本数据集包含采用贝叶斯固定效应模型（Bayesian fixed effects modeling）计算得到的卡巴他赛（cabazitaxel）、阿比特龙（abiraterone）与恩扎卢胺（enzalutamide）的中位总生存期（median overall survival）及无进展生存期（progression-free survival）风险比（hazard ratios, HRs）与95%可信区间（95% Credible Intervals）。